In a 13-year-old asymptomatic male with an anomalous right coronary artery arising from the left sinus (acute-angle take-off, short common ostium, 20 mm inter-arterial segment, ~21% luminal narrowing) and a negative nuclear perfusion stress test, should he be allowed to resume competitive athletics with counseling and annual follow-up, or should he be restricted from competition immediately pending definitive anatomic and surgical assessment?

Clarification of Apparent Contradiction

I apologize for the confusion. There is no actual contradiction—the recommendations differ because they address two distinct clinical scenarios based on the timing and completeness of the evaluation.

The Key Distinction

Initial presentation vs. completed evaluation determines the recommendation:

Scenario 1: At Time of Diagnosis (Initial Evaluation)

It is reasonable to temporarily withhold or limit competitive sports participation during the initial clinical evaluation of interarterial right AAOCA 1. This is the immediate restriction I referenced—it applies while you're still gathering data, performing stress tests, and assessing risk features.

Scenario 2: After Complete Evaluation (Your Patient's Current Status)

For competitive athletes with interarterial right AAOCA and no symptoms suggestive of myocardial ischemia and no evidence of inducible myocardial ischemia or complex ventricular arrhythmias, competitive sports participation is reasonable with shared decision-making (SDM) and longitudinal clinical surveillance 1. This is the "return to play with counseling and follow-up" recommendation that applies once testing is complete and negative.

Your Patient's Specific Situation

Your 13-year-old has completed the evaluation with:

• Negative nuclear perfusion stress test
• No symptoms of ischemia
• Documented anatomical features (though concerning: acute angle, 21% luminal narrowing)

He now falls into the second scenario where return to competitive sports is reasonable with proper counseling and annual surveillance 1, 2.

Important Caveats

The 2017 guidelines 2 state this more permissively: "For those without symptoms concerning for ischemia or a positive exercise stress test, and after counseling concerning the risk of SCD, participation in competitive athletics is permissible."

However, the 2025 guidelines 1 are more nuanced and emphasize shared decision-making, recognizing that:

• The 21% luminal narrowing and acute angle are concerning anatomical features
• Stress testing has limitations in detecting dynamic compression during maximal exertion
• The family must understand residual risk despite negative testing

The Clinical Algorithm

1. During initial workup → Temporary restriction from competition
2. After negative ischemia testing → Eligible for return to play
3. But requires → Detailed counseling about residual risk + annual surveillance + immediate reporting of any symptoms
4. Alternative option → Surgical repair followed by return to play after healing and repeat negative testing 1

The apparent contradiction was actually describing different time points in the same patient's care pathway. Both recommendations are correct—they just apply at different stages of evaluation and management.